SEARCH

SEARCH BY CITATION

References

  • 1
    de Oliveira EP, Burini RC. High plasma uric acid concentration: causes and consequences. Diabetol Metab Syndr 2012;4:128.
  • 2
    Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res 2011;63:10210.
  • 3
    Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, Totsuka K et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care 2009;32:173742.
  • 4
    Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res 2010;62:17080.
  • 5
    Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Care Res 2009;61:88592.
  • 6
    Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE et al. Microalbuminuria, cardiovascular risk factors and cardiovascular morbidity in a British population: the EPIC-Norfolk population-based study. Eur J Prev Cardiol 2004;11:20713.
  • 7
    Ninomiya T, Perkovic V, De Galan BE, Zoungas S, Pillai A, Jardine M et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 2009;20:181321.
  • 8
    Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbiagele B. Impact of microalbuminuria on incident stroke: a meta-analysis. Stroke 2010;41:262531.
  • 9
    Tseng CH. Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int 2005;68:796801.
  • 10
    Bellomo G, Berardi P, Saronio P, Verdura C, Esposito A, Laureti A et al. Microalbuminuria and uric acid in healthy subjects. J Nephrol 2006;19:45864.
  • 11
    Lee JE, Kim YG, Choi YH, Huh W, Kim DJ, Oh HY. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension 2006;47:9627.
  • 12
    Fukui M, Tanaka M, Shiraishi E, Harusato I, Hosoda H, Asano M et al. Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. Metabolism 2008;57:6259.
  • 13
    Rodilla E, Pérez-Lahiguera F, Costa JA, González C, Miralles A, Moral D et al. Association between serum uric acid, metabolic syndrome and microalbuminuria in previously untreated essential hypertensive patients. Med Clin 2009;132:16.
  • 14
    Kim ES, Kwon HS, Ahn CW, Lim DJ, Shin JA, Lee SH et al. Serum uric acid level is associated with metabolic syndrome and microalbuminuria in Korean patients with type 2 diabetes mellitus. J Diabetes Complications 2011;25:30913.
  • 15
    Navarro-González JF, Mora-Fernández C. The role of inflammatory cytokines in diabetic nephropathy. Adv Chronic Kidney Dis 2008;19:43342.
  • 16
    Kang DH, Chen W. Uric acid and chronic kidney disease: new understanding of an old problem. Semin Nephrol 2011;31:44752.
  • 17
    Park SK, Ryoo JH, Kim MG, Shin JY. Association of serum ferritin and the development of metabolic syndrome in middle-aged Korean men: a 5-year follow-up study. Diabetes Care 2012;35:25216.
  • 18
    Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 2004;38:6139.
  • 19
    Haapanen N, Miilunpalo S, Pasanen M, Oja P, Vuori I. Association between leisure time physical activity and 10-yr body mass change among working-aged men and women. Int J Obes Relat Metab Disord 1997;21:28896.
  • 20
    Sung KC, Wild SH, Kwag HJ, Byrne CD. Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people. Diabetes Care 2012;35:235964.
  • 21
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:4129.
  • 22
    Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:60412.
  • 23
    Houlihan CA, Tsalamandris C, Akdeniz A, Jerums G. Albumin to creatinine ratio: a screening test with limitations. Am J Kidney Dis 2002;39:11839.
  • 24
    Parving H, Lewis J, Ravid M, Remuzzi G, Hunsicker L. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006;69:205763.
  • 25
    Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002;282:F9917.
  • 26
    Sánchez-Lozada LG, Lanaspa MA, Cristóbal-García M, García-Arroyo F, Soto V, Cruz-Robles D et al. Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations. Nephron Exp Nephrol 2012;121:e718.
  • 27
    Yu MA, Sanchez-Lozada LG, Johnson RJ, Kang DH. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 2010;28:123442.
  • 28
    Addabbo F, Ratliff B, Park HC, Kuo MC, Ungvari Z, Csiszar A et al. The Krebs cycle and mitochondrial mass are early victims of endothelial dysfunction: proteomic approach. Am J Pathol 2009;174:3443.
  • 29
    Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005;67:173942.
  • 30
    Berni A, Boddi M, Fattori EB, Cecioni I, Berardino S, Montuschi F et al. Serum uric acid levels and renal damage in hyperuricemic hypertensive patients treated with Renin–Angiotensin system blockers. Am J Hypertens 2010;23:67580.
  • 31
    Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? J Am Soc Nephrol 2003;41:118390.
  • 32
    Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003;41:128793.
  • 33
    Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002;13:288897.
  • 34
    Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans role of oxidative stress. Circulation 2002;106:206772.
  • 35
    Almeida JC, Zelmanovitz T, Vaz JS, Steemburgo T, Perassolo MS, Gross JL et al. Sources of protein and polyunsaturated fatty acids of the diet and microalbuminuria in type 2 diabetes mellitus. J Am Coll Nutr 2008;27:52837.
  • 36
    Riley MD, Dwyer T. Microalbuminuria is positively associated with usual dietary saturated fat intake and negatively associated with usual dietary protein intake in people with insulin-dependent diabetes mellitus. Am J Clin Nutr 1998;67:507.
  • 37
    Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004;350:1093103.
  • 38
    Krishnan E, Lingala B, Bhalla V. Low-level lead exposure and the prevalence of Gout: an observational study. Ann Intern Med 2012;157:23341.
  • 39
    Jensen JS. Intra-individual variation of overnight urinary albumin excretion in clinically healthy middle-aged individuals. Clin Chim Acta 1995;243:959.
  • 40
    Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, Parving HH et al. Proteinuria and other markers of chronic kidney disease: a position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Am J Kidney Dis 2003;42:61722.